Literature DB >> 32421997

Correlating Transcriptional Networks to Acute Rejection in Human Kidney Transplant Biopsies.

Rong Liu1, You Zou2, Wei Zhang1, Hong Hao Zhou1.   

Abstract

Acute rejection (AR) in kidney transplants remains a major cause of allograft failure. This study investigates the association between gene networks and AR in human kidney transplant biopsies with weighted gene co-expression network analysis (WGCNA). The gene expression profiles of 403 (training set) and 702 (validation set) kidney transplant patients' biopsies were analyzed. WGCNA was conducted, and 11 co-regulated gene modules were identified. Each module was investigated with a t-test for AR and survival analysis for graft loss. The association between modules and AR molecular subtypes was also evaluated. Three transcriptional gene modules were associated with AR and graft loss of kidney transplant. One module constitutes unregulated immune response genes in AR and is associated with shorter graft survival (HR = 4.22, p-value = 4.29 × 10-6). This module is more significantly up-regulated in T cell-mediated acute rejection (TCMR) than in non-TCMRs. Hub genes such as HLA-DMA, CORO1A, PYCARD, and CD53 were identified. The expression of the other two modules was down-regulated in AR patients and associated with a good graft prognosis (HR = 0.41 and 0.24, respectively). A systems biology network approach may help uncover gene networks in kidney transplant biopsies associated with AR and contribute to identifying new biomarkers.

Entities:  

Year:  2019        PMID: 32421997     DOI: 10.1615/CritRevEukaryotGeneExpr.2019027763

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  1 in total

1.  SLAMF8 Participates in Acute Renal Transplant Rejection via TLR4 Pathway on Pro-Inflammatory Macrophages.

Authors:  Lisha Teng; Lingling Shen; Wenjun Zhao; Cuili Wang; Shi Feng; Yucheng Wang; Yan Bi; Song Rong; Nelli Shushakova; Hermann Haller; Jianghua Chen; Hong Jiang
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.